Mes choix et mouvements sont basés sur l'analyse technique des graphiques,merci pour votre attention et fidélité,le succès de chaque individu dépend de son fond, le dévouement,le désir et la motivation. Soutenir trades actions biotechs en faisant un Don via le bouton Paypal(totalement sécurisé) merci pour vôtre contribution.
Articles les plus consultés
-
francis 13 Version sans publicité Marchés Actualités Analyses Crypto Fonds Graphiques Technique Brokers Outils Portefe...
-
6% Hydroxyethyl Starch 130 / 0.4 in 0.9% Injection de chlorure de sodium (Voluven 500 mL freeflex flexible en plastique intraveineuse solut...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Iridium 14.95 + 39.07% 0,60K Mondialisation de l'Inde. 0,4800 + 18,52% 1,80K...
-
Top Gaining Stocks % Chg Dernier Symb Compagnie Le volume 16,22% 2.15 SRNE Sorrento Therapeut 7030 10,92% 2,64 CIE Cobalt Inte...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Oracle Corporation 51.30 + 10,73% 58.90K Staples Inc 9.25 + 6,81% 12,31K Delcat...
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Delcath 0.1230 + 24,24% 196,67K Neos Therapeutics I. 10.50 +16.67% 34.36K Enpha...
-
Citoyens_Français @citoyenneFrance 8 juin Plus Attali : « Les élus n’ont plus de pouvoir et voici votre avenir » - Effr......
-
Pre Market Top Gainers prénom Dernier Chg. % Vol. Lipocine In 5.32 + 32,34% 38.64K Enphase Energy Inc 0,938 + 17,57% 10,37K Delca...
-
28 juin 2017 Nom du médicament et numéro de demande Ingrédient actif Formulaire de posologie / itinéraire Soumission Compagnie ...
-
Plus fortes hausses en préouverture Nom Dernier Var.% Vol. DragonWave Inc 1,3900 +25,23% 3,55K Alibaba 139,95 +11,35% 1,40M MoSys...
vendredi 13 juillet 2018
CFN Media Exclusive Interview: Segra International's Cannabis Micropropagation Revolution
la bourse et toutes ses actions tous pays
ObsEva SA to start trading today on the SIX Swiss Exchange
la bourse et toutes ses actions tous pays
Clementia Appoints Experienced Financial Executive Steve Forte as Chief Financial Officer
la bourse et toutes ses actions tous pays
mercredi 11 juillet 2018
PAVmed Names Shaun O’Neil Chief Commercial Officer | Business Wire
PAVmed Names Shaun O’Neil Chief Commercial Officer | Business Wire: PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that it h
la bourse et toutes ses actions tous pays
Dr. Reddy\'s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market | Business Wire
Dr. Reddy\'s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market | Business Wire: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announce
la bourse et toutes ses actions tous pays
Telehealth Market in the US - Industry Outlook and Forecast 2018-2023 - ResearchAndMarkets.com | Business Wire
la bourse et toutes ses actions tous pays
mardi 10 juillet 2018
Global Artificial Organs Market 2018-2022 | 10% CAGR Projection Over the Next Four Years | Technavio | Business Wire
Global Artificial Organs Market 2018-2022 | 10% CAGR Projection Over the Next Four Years | Technavio | Business Wire: Technavio analysts forecast the global artificial organs market is expected to grow at a CAGR of around 10% during the period 2018-2022.
la bourse et toutes ses actions tous pays
lundi 9 juillet 2018
Horizon Pharma plc to Release Second-Quarter 2018 Financial Results and Host Webcast on August 8, 2018 | Business Wire
Horizon Pharma plc to Release Second-Quarter 2018 Financial Results and Host Webcast on August 8, 2018 | Business Wire: Horizon Pharma plc (Nasdaq: HZNP) announced today that its second-quarter financial results will be released on Wednesday, August 8, 2018. Following t
la bourse et toutes ses actions tous pays
jeudi 5 juillet 2018
FIT Biotech Oy: FIT Biotech Oy:n oman pääoman ehtoisten vaihtovelkakirjojen vaihtaminen osakkeiksi
la bourse et toutes ses actions tous pays
Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study
la bourse et toutes ses actions tous pays
mercredi 4 juillet 2018
CORRECTION FIT Biotech Oy: FIT Biotech\'s company site has been launched in Inderes.fi
la bourse et toutes ses actions tous pays
mardi 3 juillet 2018
Cue Health Receives ISO 13485 Certification
la bourse et toutes ses actions tous pays
NEOVACS
Néovacs : Portzamparc juge les résultats cliniques IFN K Lupus globalement très concluants et vise 1,2 euros soit un potentiel de 347%
la bourse et toutes ses actions tous pays
GEVO...ça repart
la bourse et toutes ses actions tous pays
Globus Medical Adds Two Innovative Solutions to Growing Trauma Portfolio
Globus Medical Adds Two Innovative Solutions to Growing Trauma Portfolio: Introducing ANTHEM® Ankle Fracture and Proximal Humerus Plate Systems
la bourse et toutes ses actions tous pays
Antibe Therapeutics Releases Secondary Endpoint Data from Recent Phase 2B Gastrointestinal Safety Study for Lead Drug, ATB-346 | Business Wire
Antibe Therapeutics Releases Secondary Endpoint Data from Recent Phase 2B Gastrointestinal Safety Study for Lead Drug, ATB-346 | Business Wire: ANTIBE THERAPEUTICS RELEASES SECONDARY ENDPOINT DATA FROM RECENT PHASE 2B GASTROINTESTINAL SAFETY STUDY FOR LEAD DRUG, ATB-346
la bourse et toutes ses actions tous pays
Poxel Announces Completion of Patient Enrollment for TIMES 1 Trial in the Phase 3 Registration Program for Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan | Business Wire
Poxel Announces Completion of Patient Enrollment for TIMES 1 Trial in the Phase 3 Registration Program for Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan | Business Wire: POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic diseases, in
la bourse et toutes ses actions tous pays
FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.
la bourse et toutes ses actions tous pays
dimanche 1 juillet 2018
Antibe Therapeutics Reports 2018 Year-End Financial and Operating Results | Business Wire
Antibe Therapeutics Reports 2018 Year-End Financial and Operating Results | Business Wire: ANTIBE THERAPEUTICS REPORTS 2018 YEAR-END FINANCIAL AND OPERATING RESULTS
la bourse et toutes ses actions tous pays
Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases | Business Wire
Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases | Business Wire: Alteogen and Lynkogen enter into an exclusive option agreement to develop proprietary fusion proteins for the treatment of NASH and metabolic diseases
la bourse et toutes ses actions tous pays
Inscription à :
Articles (Atom)